Aitor Aguirre is Revolutionizing Medicine by Creating “Mini Hearts” to Speed Drug Development and Improve Safety
For decades, the medical community has faced a frustrating dilemma: cardiovascular disease remains the leading cause of death worldwide, yet the pipeline for new treatments is a high-risk gamble that usually ends in failure. More than 92% of heart-related drugs that pass preclinical animal tests fail to receive FDA approval during human trials, and for complex cardiovascular conditions, success rates …